2016
DOI: 10.3748/wjg.v22.i31.7058
|View full text |Cite
|
Sign up to set email alerts
|

Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms

Abstract: Colorectal cancer (CRC) is a type of cancer with high morbidity and mortality rates worldwide and has become a global health problem. The conventional radiotherapy and chemotherapy regimen for CRC not only has a low cure rate but also causes side effects. Many studies have shown that adequate intake of fruits and vegetables in the diet may have a protective effect on CRC occurrence, possibly due to the special biological protective effect of the phytochemicals in these foods. Numerous in vitro and in vivo stud… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(40 citation statements)
references
References 98 publications
0
40
0
Order By: Relevance
“…We found that CYP24A1 expression was significantly decreased when added SFN to 1,25(OH)2D3, which is the opposite of what we hypothesized. However, in advanced Phytochemicals, such as sulforaphane, have been studied extensively for the treatment of various cancers in cell culture, animal models as well as humans (Appendix B; Yin, Wang, Qing, Lin, & Wu, 2016). They exhibit a wide range of safety and target multiple pathways in breast cancer cells (Schneider et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…We found that CYP24A1 expression was significantly decreased when added SFN to 1,25(OH)2D3, which is the opposite of what we hypothesized. However, in advanced Phytochemicals, such as sulforaphane, have been studied extensively for the treatment of various cancers in cell culture, animal models as well as humans (Appendix B; Yin, Wang, Qing, Lin, & Wu, 2016). They exhibit a wide range of safety and target multiple pathways in breast cancer cells (Schneider et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…Sulforaphane normally halts cell progression in the G0/G1 and G2/M phases, but can stop proliferation in G1/G2 [113]. …”
Section: Introductionmentioning
confidence: 99%
“…However, the in vivo efficacy of the administered PEG, despite its low bioavailability, has led some researchers to interrogate whether metabolites would be the bioactive forms of the parent compound [59,60]. Nevertheless, some studies show less pharmaceutical impact of the metabolites and indicate a decrease in the expression of SULT enzymes in certain types of cancer cells, which indicates an overall low sulfation activity in these cells comparing to the normal ones.…”
Section: Metabolismmentioning
confidence: 99%
“…RSV undergoes extensive phase I (oxidation, reduction, and hydrolysis) and phase II (glucuronic acid, sulfate, and methyl conjugations) biochemical changes immediately after ingestion [60,61], being metabolized into both glucuronic acid and sulfate conjugations of the phenolic groups in liver and intestinal epithelial cells [60][61][62][63]. Hydrogenation of the aliphatic double bond is also present [64].…”
Section: Metabolismmentioning
confidence: 99%
See 1 more Smart Citation